[go: up one dir, main page]

EP1107740A4 - Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine - Google Patents

Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine

Info

Publication number
EP1107740A4
EP1107740A4 EP98941051A EP98941051A EP1107740A4 EP 1107740 A4 EP1107740 A4 EP 1107740A4 EP 98941051 A EP98941051 A EP 98941051A EP 98941051 A EP98941051 A EP 98941051A EP 1107740 A4 EP1107740 A4 EP 1107740A4
Authority
EP
European Patent Office
Prior art keywords
detablet
pseudoephedrin
naproxen
time
released release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98941051A
Other languages
German (de)
English (en)
Other versions
EP1107740A1 (fr
Inventor
Chris E Platt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1998/017625 external-priority patent/WO2000010537A1/fr
Publication of EP1107740A1 publication Critical patent/EP1107740A1/fr
Publication of EP1107740A4 publication Critical patent/EP1107740A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP98941051A 1998-08-25 1998-08-25 Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine Withdrawn EP1107740A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/017625 WO2000010537A1 (fr) 1997-03-19 1998-08-25 Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine

Publications (2)

Publication Number Publication Date
EP1107740A1 EP1107740A1 (fr) 2001-06-20
EP1107740A4 true EP1107740A4 (fr) 2002-03-06

Family

ID=22267747

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98941051A Withdrawn EP1107740A4 (fr) 1998-08-25 1998-08-25 Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine

Country Status (5)

Country Link
EP (1) EP1107740A4 (fr)
JP (1) JP2002523358A (fr)
AU (1) AU758880B2 (fr)
CA (1) CA2341485A1 (fr)
MX (1) MXPA01001969A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2184058B1 (fr) * 2003-09-26 2012-02-08 ALZA Corporation Enrobage de médicaments à charge médicamenteuse élevée et procès de fabrication
RU2019109695A (ru) 2016-09-26 2020-10-26 Дзе Проктер Энд Гэмбл Компани Лекарственная форма для пролонгированного ослабления симптомов
US11819482B2 (en) 2017-08-29 2023-11-21 Conrig Pharma Aps Composition comprising suplatast tosilate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004022A1 (fr) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Utilisation de compositions contenant des derives de l'acide 2-(6'-substitue-2'-naphtyle)-acetique pour le traitement de troubles respiratoires
WO1995007103A1 (fr) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions contenant un sel d'acide amine d'un agent anti-inflammatoire non steroidien a base d'acide propionique et au moins un decongestionnant ou un expectorant ou un antihistaminique ou un antitussif
US5681582A (en) * 1993-06-14 1997-10-28 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
EP0811374A1 (fr) * 1996-05-29 1997-12-10 Pfizer Inc. Formulation d'une combinaison de cetirizine et pseudoephedrine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004022A1 (fr) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Utilisation de compositions contenant des derives de l'acide 2-(6'-substitue-2'-naphtyle)-acetique pour le traitement de troubles respiratoires
US5681582A (en) * 1993-06-14 1997-10-28 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
WO1995007103A1 (fr) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions contenant un sel d'acide amine d'un agent anti-inflammatoire non steroidien a base d'acide propionique et au moins un decongestionnant ou un expectorant ou un antihistaminique ou un antitussif
EP0811374A1 (fr) * 1996-05-29 1997-12-10 Pfizer Inc. Formulation d'une combinaison de cetirizine et pseudoephedrine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0010537A1 *

Also Published As

Publication number Publication date
AU8919898A (en) 2000-03-14
MXPA01001969A (es) 2002-04-24
EP1107740A1 (fr) 2001-06-20
AU758880B2 (en) 2003-04-03
JP2002523358A (ja) 2002-07-30
CA2341485A1 (fr) 2000-03-02

Similar Documents

Publication Publication Date Title
DE69929246D1 (de) Katheterschaft mit mehreren leitungen und verstärkung
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
DE69810608D1 (de) Eingekapseltes material mit kontrollierter freisetzung
NO2011010I1 (no) Naproksen- og esomeprazoltabletter med modifisert frisetting
DE69936792D1 (de) Absorbierender artikel mit wiederverwendbarer verschlussnaht
EP1032377A4 (fr) 2-aminoacetamides substitues et leur utilisation
DE69902414D1 (de) Effiziente sichere Mehrfachübertragung mit minimaler Kenntnis
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
DE69506086D1 (de) Zusammensetzung mit gesteuerter freisetzung
PL348915A1 (en) Traffic element with illumination and transparent plastic component therefor with illumination means
DK0946156T3 (da) Drikkelig ibuprofensammensætning
ID27776A (id) Bahan dengan efek antidepresan
ID30114A (id) Zat-zat herbisida dengan fenoksisulfonilurea tersubstitusi
DE69919455D1 (de) Förderer mit mehreren Trennmitteln
ID24196A (id) Komposisi dan penggunaan
ATE237929T1 (de) Mikrokapseln mit von basen ausgelöste freisetzung
NO993188L (no) Fartöy med svivelanordning
DE69904279D1 (de) Aromatisches Polycarbodiimid und Polycarbodiimidfolie
SG68709A1 (en) Styrene resin and resin composition comprising the same
DE69933475D1 (de) Schnellentriegelbare und -verriegelbare abdeckung
DE69908772D1 (de) Geraet mit kontextumschaltungsfaehigkeit
EP0984448A4 (fr) Mecanisme d'inversion de disque et changeur automatique de disque equipe de ce mecanisme
GB9907687D0 (en) Assays methods and means
EP1107740A4 (fr) Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010321

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020117

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 9/22 A, 7A 61K 9/32 B, 7A 61K 9/36 B, 7A 61K 31/137 B, 7A 61K 31/192 B

17Q First examination report despatched

Effective date: 20020704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030115